Quantum Biopharma Ltd. Files March 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Mar 26, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Mar 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Quantum Biopharma filed its March 6-K, confirming its foreign private issuer status and 20-F reporting.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on March 26, 2025, reporting for the month of March 2025. The company, incorporated in A6 with its principal executive office in Toronto, Canada, is in the Pharmaceutical Preparations industry. This filing indicates they are a foreign private issuer and will file annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and the market regarding Quantum Biopharma's status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer
- FSD Pharma Inc. (company) — Former company name
- March 2025 (date) — Reporting period
- 20250326 (date) — Filing date
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
FAQ
What is the primary business of Quantum Biopharma Ltd.?
Quantum Biopharma Ltd. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was the company formerly known as?
The company was formerly known as FSD Pharma Inc., with a name change date of March 27, 2019.
What is the principal executive office address?
The principal executive office is located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
Does Quantum Biopharma file annual reports under Form 20-F or 40-F?
Quantum Biopharma indicates it files annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed on March 26, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 26, 2025 regarding Quantum Biopharma Ltd. (QNTM).